Cargando…
In Vitro Investigations on Optimizing and Nebulization of IVT-mRNA Formulations for Potential Pulmonary-Based Alpha-1-Antitrypsin Deficiency Treatment †
In vitro-transcribed (IVT) mRNA has come into focus in recent years as a potential therapeutic approach for the treatment of genetic diseases. The nebulized formulations of IVT-mRNA-encoding alpha-1-antitrypsin (A1AT-mRNA) would be a highly acceptable and tolerable remedy for the protein replacement...
Autores principales: | Guan, Shan, Darmstädter, Max, Xu, Chuanfei, Rosenecker, Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399093/ https://www.ncbi.nlm.nih.gov/pubmed/34452241 http://dx.doi.org/10.3390/pharmaceutics13081281 |
Ejemplares similares
-
Nebulisation of IVT mRNA Complexes for Intrapulmonary Administration
por: Johler, Sarah M., et al.
Publicado: (2015) -
Nebulizers effectiveness on pulmonary delivery of alpha-1 antitrypsin
por: Bianchera, Annalisa, et al.
Publicado: (2023) -
Nanotechnologies in Delivery of DNA and mRNA Vaccines to the Nasal and Pulmonary Mucosa
por: Tang, Jie, et al.
Publicado: (2022) -
Advancements of in vitro transcribed mRNA (IVT mRNA) to enable translation into the clinics
por: Kang, Diana D., et al.
Publicado: (2023) -
SERPINA1 mRNA as a Treatment for Alpha-1 Antitrypsin Deficiency
por: Connolly, Brendan, et al.
Publicado: (2018)